Merck & Co (NYSE:MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted priority review to its ...
Abidi, H. , Ghazzar, F. and Bellemkhannate, S. (2025) Maxillofacial Prosthesis for Partial Edentulism with Maxillary Bone Loss. Health, 17, 13-22. doi: 10.4236/health.2025.171002 .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback